Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection

Sponsor
SAVA Technologies Ltd.
Study ID
NCT07679347
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • CGM Devices — DEVICE
    Each participant will wear 3 SAVA CGMs and 1 commercially available CGM

Study Details

The goal of this clinical trial is to evaluate the safety and performance of the SAVA Continuous Glucose Monitor across glucose ranges over a period of 15-day wear in adults over 18 years of age with Type 1 Diabetes. This is a pilot study, so the main purposes are to collect preliminary data for future studies, assess comfort and safety, and explore the accuracy of the CGM against references and benchmarks.

Key Dates

First listed
Jul 1, 2026
Start date
Aug 31, 2026
Status verified
Jul 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: CGM Arm

Primary Outcome Measure

Paired Sensor-Venous Blood Glucose Readings [ Time Frame: For the duration of time the participant is wearing the CGM device (Day 0 to Day 14; up to 15 days) ]

Find similar trials

Nationwide
Type 1 diabetes trialsEndocrinology trials

Related Studies